01 247BOEHRINGER INGELHEIM
01 510022379*PED
02 110034877*PED
03 610258637*PED
04 310973827*PED
05 311033552*PED
06 611090323*PED
07 127407955
08 127407955*PED
09 67579449
10 67579449*PED
11 67713938
12 67713938*PED
13 68551957
14 68551957*PED
15 88673927
16 88673927*PED
17 48846695
18 48846695*PED
19 18853156
20 18853156*PED
21 128883805
22 128883805*PED
23 99155705
24 59155705*PED
25 49173859
26 29173859*PED
27 99415016
28 19486526
29 49555001
30 69949998
31 910022379
32 110034877
33 610258637
34 410406172
35 810596120
36 310973827
37 311033552
38 611090323
39 311564886
40 1211833166
41 611911388
42 59415016*PED
43 19486526*PED
44 29555001*PED
45 49949998*PED
01 24Y
02 223Blank
01 88Y
02 159Blank
01 122025-05-02
02 122025-11-02
03 122025-11-26
04 122026-05-26
05 62027-04-15
06 152027-05-04
07 62027-10-15
08 132027-11-04
09 62028-08-01
10 62029-02-01
11 212029-04-02
12 22029-08-05
13 132029-10-02
14 62029-10-14
15 22030-02-05
16 62030-04-10
17 62030-04-14
18 92030-05-21
19 42030-06-04
20 42030-06-15
21 52030-11-21
22 42030-12-04
23 12031-03-05
24 12031-09-05
25 112032-03-07
26 42033-03-06
27 22033-09-06
28 242034-04-03
29 62034-06-11
30 122034-10-03
31 42034-12-11
Patent Expiration Date : 2027-05-04
US Patent Number : 9173859
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206073
Patent Use Code : U-1772
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2031-03-05
US Patent Number : 8853156
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 201280
Patent Use Code : U-1642
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2031-03-05
Patent Expiration Date : 2027-05-04
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8673927
Drug Substance Claim :
Drug Product Claim :
Application Number : 201281
Patent Use Code : U-1503
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2027-05-04
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8673927
Drug Substance Claim :
Drug Product Claim :
Application Number : 201281
Patent Use Code : U-1503
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2027-05-04
US Patent Number : 8673927
Drug Substance Claim :
Drug Product Claim :
Application Number : 201280
Patent Use Code : U-1503
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2027-05-04
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9173859
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208026
Patent Use Code : U-1503
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2033-03-06
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9555001
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208026
Patent Use Code : U-1967
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-03-06
Patent Expiration Date : 2033-03-06
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9555001
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208026
Patent Use Code : U-1968
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-03-06
Patent Expiration Date : 2029-10-14
US Patent Number : 8551957
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206073
Patent Use Code : U-1651
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2029-10-14
Patent Expiration Date : 2030-06-04
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8846695
Drug Substance Claim :
Drug Product Claim :
Application Number : 201281
Patent Use Code : U-1503
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2030-06-04
LOOKING FOR A SUPPLIER?
